Airsonett supports the Allergy Diary App – assists in the care of allergic asthma
The new app Allergy Diary has been developed for IOS and Android in collaboration between MACVIA-LR and ARIAR, a European network for monitoring allergy. The app is an important tool for the effective treatment of severe allergic asthma as it assists patients in keeping track of their symptoms. The app is simple to use, and combines practicality with good scientific practice, having been developed with a global team of world leading allergy clinicians. The app can be downloaded here (https://itunes.apple.com/fi/app/allergy-diary-by-macvia-aria/id983596216?mt=8,https://play.google.com/store/apps/details?id=nl.peercode.allergydiary&hl=en) and on Airsonett's website.
“In order for the healthcare system to be able to follow the daily changes, the importance of some form of symptom diary is great” says Therese Sterner, Leg. Allergy, Asthma and COPD nurse with skin specialization. She continues: “This can easily be done through the Allergy Diary app. Studies have shown positive results with this form of allergy diary, as it monitors symptom changes over time which assists both the user and the health care system,”.
Anders Due-Boje, CEO of Airsonett, agrees: “In all treatment it is of the utmost importance that patients can document their symptoms. We support this app to help patients easily keep track of their symptoms so the national health services can provide optimal care for each patient. "
Airsonett is a unique treatment for allergic asthma
Airsonett® Air4 is a medical device for effective home treatment of allergic asthma and eczema. The patented TLA technology provides 99.5% clean air in the breathing zone. Your airways and immune system can rest and recuperate when you sleep, and you wake up rested, ready for a new day. The technology is clinically documented for several years and now wins land in many county councils.
"As my role as an Allergy Nurse, both in the County Council and as a consultant, I monitor children and adults since 2007 with severe asthma who have an Airsonett installed. Sleeping under an Airsonett has, with a few exceptions, resulted in huge improvements for the individual patient but also for the family. Sleeping undisturbed without coughing and itching a whole night increases the possibility of a better everyday life”, says Therese Sterner, Leg. Allergy, Asthma and COPD nurse with skin specialization.
For more information:
Anders Due-Boje, CEO, Airsonett AB
Tel: +46 70 526 03 00
E-mail: anders.due-boje@airsonett.eu
About Airsonett
Airsonett® är ett svenskt medicintekniskt företag som är ledande inom icke-farmakologisk behandling av patienter med allergisk svår, okontrollerad astma och eksem. Airsonett® Air4 är en icke-invasiv medicinsk utrustning för hembehandling baserad på den patenterade tekniken Temperatur-reglerat laminärt luftflöde (TLA). Behandling med Airsonett® Air4 medför drastisk minskning av allergener och andra luftburna partiklar i patientens andningszon under vila och sömn. Airsonett® Air4 rekommenderas av Socialstyrelsen och Barnläkarföreningen samt ingår sedan 2015 i Läkemedelsverkets riktlinjer för astmabehandling. Airsonett® Air4 är en CE-märkt medicinteknisk utrustning, Klass 1, avsedd att användas för lindring av symtom vid allergiska sjukdomar såsom allergisk astma och eksem. Den följer relevanta EU-direktiv gällande utformning, funktion, säkerhet, hälsokrav och har genomgått rigorös klinisk forskning så väl som hälsoekonomiska analyser. Airsonett® Air4 innehar ett 510(k) godkännande, klass II, från FDA. Bolagets huvudägare är SEB Venture Capital, Industrifonden och Magnus Lundberg. För ytterligare information, besök www.airsonett.se
Powered by Notified